Stock Market Update - March 19, 2026
Today's stock market saw some significant movers. Here's a breakdown of 5 stocks that caught our attention:
1. ANGIV - Angi Inc. Class A Common Stock When Issued
Price: $15.76 | Change: +100.00% ($15.76)
ANGIV:NASDAQ experienced an alleged 100.00% gain around March 2026, but this requires a closer look. ANGIV was a temporary "when-issued" ticker used briefly in March 2025 during Angi Inc.'s spin-off from IAC Inc., ceasing trading by the end of that month. Therefore, any significant movement attributed to ANGIV a year later is likely a data misattribution or error.
The actual company, Angi Inc., trades under the ticker ANGI. In early March 2026, ANGI shares actually saw an 8.6% jump. This positive movement was driven by the exciting news that Angi had launched its app within ChatGPT, offering an innovative AI-guided hiring journey for homeowners looking for services.
This move to integrate with a major AI platform is a notable strategic step for Angi, potentially expanding its reach and streamlining the user experience through artificial intelligence. While not the dramatic 100% reported for the defunct ticker, the 8.6% increase highlights investor optimism about Angi's focus on technological innovation.
2. SER - Serina Therapeutics, Inc.
Price: $2.48 | Change: +93.77% ($1.2001)
SER:AMEX just saw a significant jump, with reports indicating a 93.77% gain. This surge is primarily thanks to Serina Therapeutics, Inc. announcing a new private placement financing, where they entered agreements to raise up to $30 million.
The company plans to raise this capital by selling common stock and pre-funded warrants, with the first $15 million tranche expected to close soon. What's particularly notable is that this offering was priced at a substantial 68% premium to the stock's recent closing price. This fresh capital is crucial for advancing Serina's lead program, SER-252, which is undergoing trials for advanced Parkinson's disease.
This funding is expected to extend the company's operating runway into the second half of 2027, providing more time for their research and development efforts. Additionally, the involvement of Greg Bailey, M.D., a respected figure in the biotech sector, as Co-Chairman of the Board has also contributed to positive investor sentiment.
3. WETO - Webus International Limited Ordinary Shares
Price: $0.692 | Change: +64.64% ($0.2717)
WETO saw a significant jump, gaining 64.64%, primarily due to a major corporate rebranding and a successful capital raise. Formerly Webus International, the company officially changed its name to Wetour Robotics on March 17, 2026. This signaled a strategic pivot from a travel technology provider to a Physical AI infrastructure company specializing in wearable robotics, including establishing a U.S. headquarters in Austin, Texas.
Further bolstering investor confidence, Wetour Robotics completed a private investment in public equity (PIPE) transaction, raising $5.16 million by selling 60 million shares to certain non-U.S. investors. The combination of this clear strategic shift into a potentially high-growth sector and new funding to support its new direction appears to be the main catalyst behind WETO's substantial stock movement.
4. LNKS - Linkers Industries Limited
Price: $0.88 | Change: +51.36% ($0.2986)
LNKS enjoyed a significant 51.36% gain, primarily fueled by a flurry of strategic financial announcements in mid-March 2026. The company filed a preliminary prospectus for a public offering of units, aiming to raise approximately $16.25 million. These funds are intended to boost Linkers Industries' stake in LPW Electronics, where it currently holds 20%, along with supporting capital expenditures and general corporate needs.
The market responded with enthusiasm, as the stock saw a 63.4% surge in pre-market trading shortly after the unit offering was announced. This positive reaction indicates that investors are embracing Linkers Industries' plans for strategic expansion and an infusion of capital. Furthermore, the company's decision to adopt home-country governance practices offers greater flexibility in its corporate structure and fundraising.
This recent movement underscores how strategic business developments, particularly those focused on growth and capital generation, can quickly impact investor confidence and drive stock performance.
5. IPEXR - Inflection Point Acquisition Corp. V
Price: $0.49 | Change: +48.48% ($0.16)
IPEXR experienced an impressive 48.48% gain around March 20, 2026. While no direct news or specific catalyst for Inflection Point Acquisition Corp. V (IPEXR) itself was found to explain this sudden spike, IPEXR is a Special Purpose Acquisition Company (SPAC) that went public in late 2025 and is currently on the hunt for a business to merge with.
The timing of IPEXR's rise coincided with a flurry of activity from other SPACs within the same "Inflection Point" family. Just days prior, Inflection Point Acquisition Corp. IV (BACQ) successfully completed its merger with aerospace and defense tech company Merlin, Inc., which began trading under a new ticker. Additionally, Inflection Point Acquisition Corp. III (IPCX) announced a significant increase to its private investment. Although these events didn't directly involve IPEXR, the positive momentum and increased visibility surrounding the broader Inflection Point SPAC group likely drew investor attention, potentially influencing IPEXR's stock movement.
This analysis was generated using AI and real-time stock data. Always do your own research before making investment decisions.